39 related articles for article (PubMed ID: 36179331)
21. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain].
Watanabe H
Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.
Iqbal K; Alonso AC; Gong CX; Khatoon S; Pei JJ; Wang JZ; Grundke-Iqbal I
J Neural Transm Suppl; 1998; 53():169-80. PubMed ID: 9700655
[TBL] [Abstract][Full Text] [Related]
23. SPECT and PET imaging in Alzheimer's disease.
Valotassiou V; Malamitsi J; Papatriantafyllou J; Dardiotis E; Tsougos I; Psimadas D; Alexiou S; Hadjigeorgiou G; Georgoulias P
Ann Nucl Med; 2018 Nov; 32(9):583-593. PubMed ID: 30128693
[TBL] [Abstract][Full Text] [Related]
24. Tau PET Imaging for Staging of Alzheimer's Disease in Down Syndrome.
Rafii MS
Dev Neurobiol; 2019 Jul; 79(7):711-715. PubMed ID: 30536948
[TBL] [Abstract][Full Text] [Related]
25. Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease.
Cohen AD; Landau SM; Snitz BE; Klunk WE; Blennow K; Zetterberg H
Mol Cell Neurosci; 2019 Jun; 97():3-17. PubMed ID: 30537535
[TBL] [Abstract][Full Text] [Related]
26. Developments in Tau PET Imaging.
Zimmer ER; Leuzy A; Gauthier S; Rosa-Neto P
Can J Neurol Sci; 2014 Sep; 41(5):547-53. PubMed ID: 25424608
[TBL] [Abstract][Full Text] [Related]
27. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
Bloom GS
JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
[TBL] [Abstract][Full Text] [Related]
28. Correlation of Alzheimer Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers.
Koychev I; Hofer M; Friedman N
J Nucl Med; 2020 Oct; 61(10):1413-1418. PubMed ID: 32764121
[TBL] [Abstract][Full Text] [Related]
29. Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions.
Villemagne VL; Doré V; Burnham SC; Masters CL; Rowe CC
Nat Rev Neurol; 2018 Apr; 14(4):225-236. PubMed ID: 29449700
[TBL] [Abstract][Full Text] [Related]
30. Tau PET imaging in Alzheimer's disease.
Okamura N; Harada R; Furumoto S; Arai H; Yanai K; Kudo Y
Curr Neurol Neurosci Rep; 2014 Nov; 14(11):500. PubMed ID: 25239654
[TBL] [Abstract][Full Text] [Related]
31. Combination of Astrogliosis and Phosphorylated Tau for the Preclinical Diagnosis of Alzheimer Disease Using 3-Dimensional Stereotactic Surface Projection Images With 18 F-THK5351.
Imabayashi E; Saitoh Y; Tsukamoto T; Sakata M; Takano H
Clin Nucl Med; 2022 Dec; 47(12):1066-1068. PubMed ID: 36179331
[TBL] [Abstract][Full Text] [Related]
32. [Imaging of neuropathology by PET tracers].
Harada R
Nihon Yakurigaku Zasshi; 2022; 157(6):453-457. PubMed ID: 36328560
[TBL] [Abstract][Full Text] [Related]
33. In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings.
Hall B; Mak E; Cervenka S; Aigbirhio FI; Rowe JB; O'Brien JT
Ageing Res Rev; 2017 Jul; 36():50-63. PubMed ID: 28315409
[TBL] [Abstract][Full Text] [Related]
34. Tau PET imaging in neurodegenerative tauopathies-still a challenge.
Leuzy A; Chiotis K; Lemoine L; Gillberg PG; Almkvist O; Rodriguez-Vieitez E; Nordberg A
Mol Psychiatry; 2019 Aug; 24(8):1112-1134. PubMed ID: 30635637
[TBL] [Abstract][Full Text] [Related]
35. Imaging of Tau Pathology in Neurodegenerative Diseases: An Update.
Beyer L; Brendel M
Semin Nucl Med; 2021 May; 51(3):253-263. PubMed ID: 33353724
[TBL] [Abstract][Full Text] [Related]
36. Clinical application of MAO-B PET using
Ishibashi K
Geriatr Gerontol Int; 2024 Mar; 24 Suppl 1():31-43. PubMed ID: 37973072
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
